AlphaCentric Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$400K	Buy	+12,614	New	+$344K	0.4%	87
2024 Q4	–	Sell	-30,000	Closed	-$1.02M	–	224
2024 Q3	$1.02M	Sell	30,000 -17,500	-37%	-$667K	0.76%	44
2024 Q2	$1.76M	Buy	47,500 +9,000	+23%	+$340K	1.29%	19
2024 Q1	$1.62M	Buy	+38,500	New	+$1.58M	0.97%	32
2023 Q4	–	Sell	-15,000	Closed	-$413K	–	237
2023 Q3	$413K	Hold	15,000	–	–	0.23%	97
2023 Q2	$509K	Hold	15,000	–	–	0.28%	95
2023 Q1	$540K	Hold	15,000	–	–	0.37%	84
2022 Q4	$669K	Sell	15,000 -2,000	-12%	-$71.4K	0.66%	56
2022 Q3	$478K	Buy	+17,000	New	+$521K	0.49%	57
2021 Q4	$657K	Hold	17,000	–	–	0.19%	54
2021 Q3	$918K	Sell	17,000 -8,000	-32%	-$375K	0.23%	37
2021 Q2	$836K	Hold	25,000	–	–	0.23%	34
2021 Q1	$515K	Buy	25,000 +21,500	+614%	+$494K	0.17%	43
2020 Q4	$61K	Hold	3,500	–	–	0.03%	170
2020 Q3	$52K	Buy	+3,500	New	+$41K	0.03%	104